(2014). Erbb2+metastatic breast cancer treatment after progression on trastuzumab: A cost-effectiveness analysis for a developing country.
Chicago Style (17th ed.) CitationErbb2+metastatic Breast Cancer Treatment After Progression on Trastuzumab: A Cost-effectiveness Analysis for a Developing Country. 2014.
MLA (8th ed.) CitationErbb2+metastatic Breast Cancer Treatment After Progression on Trastuzumab: A Cost-effectiveness Analysis for a Developing Country. 2014.
Warning: These citations may not always be 100% accurate.